Line field confocal optical coherence tomography: An adjunctive tool in the diagnosis of autoimmune bullous diseases.
Linda TognettiElisa CinottiMariano SuppaRaffaella GuazzoCyril HabougitFrancesco SantiGwendoline DietMargot FontaineVincent BerotJilliana MonnierElisa PianigianiVéronique Del MarmolJoseph MalvehyJean-Luc PerrotPietro RubegniPublished in: Journal of biophotonics (2021)
Autoimmune bullous diseases (AIBDs) still represent a considerable a source of morbidity and mortality: early identification of a specific AIBD is often difficult due to overlapping clinical and/or laboratory features and time-consuming invasive laboratory tests. We aimed to investigate the potential role of a new imaging technology, line-field confocal optical coherence tomography (LC-OCT), in the non-invasive diagnosis of AIBDs. LC-OCT was performed at lesional, perilesional and contralateral healthy sites in 30 patients, before histology and direct immunofluorescence. LC-OCT examination was able to identify the level of split (subcorneal/suprabasal/subepidermal/sublamina densa), to provide detailed images of the bulla roof morphology and content (eg, erythrocytes/acantholytic cells/polymorphonucleates). Areas of intra/subepidermal detachment were also detected also at clinically normal perilesional skin sites. LC-OCT can support physicians, real time and at bed-site, in the differential diagnosis of various AIBDs and their mimickers. Moreover, it can be used for the identification of subclinical lesions and therapy tapering.
Keyphrases
- optical coherence tomography
- diabetic retinopathy
- simultaneous determination
- optic nerve
- end stage renal disease
- multiple sclerosis
- newly diagnosed
- mass spectrometry
- ejection fraction
- chronic kidney disease
- primary care
- induced apoptosis
- prognostic factors
- mesenchymal stem cells
- cell cycle arrest
- patient reported outcomes
- risk assessment
- drug induced
- signaling pathway
- wound healing
- smoking cessation
- bone marrow
- cell therapy
- patient reported